Moody Aldrich Partners LLC purchased a new position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 82,460 shares of the biopharmaceutical company’s stock, valued at approximately $4,532,000. Moody Aldrich Partners LLC owned about 0.07% of Cytokinetics […]

Moody Aldrich Partners LLC grew its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 62.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 73,716 shares of the biopharmaceutical company’s stock after acquiring an additional 28,304 shares during the […]

Moody Aldrich Partners LLC increased its stake in Nomad Foods Limited (NYSE:NOMD – Free Report) by 188.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 247,558 shares of the company’s stock after acquiring an additional 161,623 shares during the period. Moody Aldrich Partners LLC owned about […]